• Effect of Low Magnetic Field on Dose Distribution in the SABR Plans for Liver Cancer

• ¼ÕÀ縸(Son Jae-Man) Àü¹Î¼ö(Chun Min-Soo) ¾ÈÇöÁØ(An Hyun-Joon) °­¼ºÈñ(Kang Seong-Hee) ÁöÀDZÔ(Chie Eui-Kyu) À±Á¤¹Î(Yoon Jeong-Min) ÃÖâÇå(Choi Chang-Heon) ¹ÚÁ¾¹Î(Park Jong-Min) ±èÁ¤ÀÎ(Kim Jung-In)

• Progress in Medical Physics  2018³â 29±Ç 2È£ 47~52

• Epidemiology of liver cancer in South Korea

• ±èº¸Çö(Kim Bo-Hyun) ¹ÚÁß¿ø(Park Joong-Won)

• Clinical and Molecular Hepatology  2018³â 24±Ç 1È£ 1~9

• 2014 The Korean Liver Cancer Study Group and the National Cancer Center °£¼¼Æ÷¾ÏÁ¾ °³Á¤ °¡À̵å¶óÀÎ: 1 cm ¹Ì¸¸ °£¼¼Æ÷¾ÏÁ¾ÀÇ ºñħ½ÀÀû Áø´Ü±âÁØÀÌ ³Ê¹« ¾ö°ÝÇÑ°¡?

• Noninvasive Diagnostic Criteria of the Revised 2014 the Korean Liver Cancer Study Group and the National Cancer Center Guideline for Subcentimetersized Hepatocellular Carcinoma: Is It Too Strict?

• ±è³²Áß(Kim Nam-Joong) ½Åµ¿Çö(Sinn Dong-Hyun) °­¿ø¼®(Kang Won-Seok) ¹é¿ëÇÑ(Paik Yong-Han) ÃÖ¹®¼®(Choi Moon-Seok) ÀÌÁØÇõ(Lee Joon-Hyoek) °í±¤Ã¶(Koh Kwang-Cheol) ¹é½Â¿î(Paik Seung-Woon) °û±Ý¿¬(Gwak Geum-Youn)

• Journal of Liver Cancer  2018³â 18±Ç 1È£ 44~50

• Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms

• ÀÌ¿µ¼±(Lee Young-Sun) ¼­¿¬¼®(Seo Yeon-Seok) ±èÁöÈÆ(Kim Ji-Hoon) ÀÌÁØ¿µ(Lee June-Young) ±èÇظ²(Kim Hae-Rim) À¯¾çÀç(Yoo Yang-Jae) ±èż®(Kim Tae-Suk) °­¼ºÈñ(Kang Seong-Hee) ¼­»óÁØ(Suh Sang-June) ÁÖ¹®°æ(Joo Moon-Kyung) Á¤¿µ°É(Jung Young-Kul) À̹üÀç(Lee Beom-Jae) ÀÓÇüÁØ(Yim Hyung-Joon) ¿¬Á¾Àº(Yeon Jong-Eun) ±èÀç¼±(Kim Jae-Seon) ¹ÚÁ¾Àç(Park Jong-Jae) ¾ö¼øÈ£(Um Soon-Ho) ¹Ú¿µÅÂ(Bak Young-Tae) º¯°ü¼ö(Byun Kwan-Soo)

• Gut and Liver  2018³â 12±Ç 1È£ 94~101

• Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma

• ¼­¼®¿ø(Suh Suk-Won) ÃÖÀ¯½Å(Choi Yoo-Shin)

• Yonsei Medical Journal  2017³â 58±Ç 4È£ 737~742

• A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function

• ¾çÇö(Yang Hyun) ¿ìÇö¿µ(Woo Hyun-Young) À̼ø±Ô(Lee Soon-Kyu) À庸Çö(Jang Bo-Hyun) ³²Èñö(Nam Hee-Chul) ÀÌÇظ²(Lee Hae-Lim) À̼º¿ø(Lee Sung-Won) ¼Ûµµ¼±(Song Do-Seon) ¼Û¸íÁØ(Song Myeong-Jun) ¿ÀÁ¤¼®(Oh Jung-Suk)

• Clinical and Molecular Hepatology  2017³â 23±Ç 2È£ 128~137

• Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors

• (Thorat Ashok) (Jeng Long-Bin) (Yang Horng-Ren) (Yeh Chun-Chieh) (Hsu Shih-Chao) (Chen Te-Hung) (Poon Kin-Shing)

• Çѱ¹°£´ãÃé¿Ü°úÇÐȸÁö  2017³â 21±Ç 4È£ 205~211

• °£¾Ï ±¹°¡¾Ï°ËÁø»ç¾÷¿¡ Âü¿©ÇÑ ¸¸¼ºBÇü°£¿° ȯÀÚ¿¡¼­ °£¾Ï ¹ß»ý·ü Á¶»ç

• Incidence of Primary Liver Cancer in Subjects with Chronic Hepatitis B in Korean National Liver Cancer Screening Program

• ÃÖÀνÂ(Choi In-Seung) ¿ÀÄ¡Çõ(Oh Chi-Hyuk) ¹Ú¼Ò¿µ(Park So-Young) ¾È¼ºÀº(Ahn Sung-Eun) ¹Ú¼ºÁø(Park Seong-Jin) ÃÖÇö¸²(Choi Hyun-Rim) ±èº´È£(Kim Byung-Ho) ½ÉÀçÁØ(Shin Jae-Jun)

• Journal of Liver Cancer  2017³â 17±Ç 2È£ 136~143

• °£¾Ï µ¿¹°¸ðµ¨ÀÇ ÇöȲ ¹× ÀüÀÓ»ó ¿¬±¸¿¡¼­ÀÇ È°¿ë

• AnimalAnimal Models of Liver Cancer: Current Status and Application in Preclinical Research

• ÁÖÇý¸²(Ju Hye-Lim) ³ë¿ø»ó(Ro Weon-Sang)

• Journal of Liver Cancer  2017³â 17±Ç 1È£ 1~14

• °£µ¿¸Æ È­ÇлöÀü¼úÀ» ¹ÞÀº °£¾ÏȯÀÚÀÇ ¿µ¾ç»óÅ¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ

• Influencing Factors of Nutritional Status among Liver Cancer Patients Receiving Transcatheter Arterial Chemoembolization(TACE)

• ¼Õ¿µ½Ç(Sohn Young-Sil) °­Àμ÷(Kang In-Soon)

• º¸°ÇÀÇ·á»ê¾÷ÇÐȸÁö  2017³â 11±Ç 1È£ 159~169

• Current Status of the National Liver Cancer Surveillance Program in Korea

• ½Å»óÁø(Shin Sang-Jin) ÃÖÇÏÁø(Tchoe Ha-Jin) ÀÌÀÚ¿¬(Lee Ja-Youn) ¼­Àç°æ(Suh Jae-Kyung) ±ÇÁø¿ø(Kwon Jin-Won)

• º¸°ÇÀÇ·á±â¼úÆò°¡  2017³â 5±Ç 2È£ 102~107

• °£¾Ï °¨½Ã°Ë»çÀÇ ºñ¿ë-È¿°úºÐ¼®: ü°èÀû ¹®Çå°íÂû

• Cost-Effectiveness of Surveillance for Hepatocellular Carcinoma: A Systematic Review

• ¼­Àç°æ(Suh Jae-Kyung) ÃÖÇÏÁø(Tchoi Ha-Jin) ¾çÀå¹Ì(Yang Jang-Mi) ½Å»óÁø(Shin Sang-Jin)

• º¸°ÇÀÇ·á±â¼úÆò°¡  2017³â 5±Ç 1È£ 49~58

• Learning Laparoscopic Liver Resection for Liver Cancer

• (Cheung Tan To)

• Journal of Digestive Cancer Research  2017³â 5±Ç 1È£ 28~31

• A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer

• ³²¼öÁ¤(Nam Soo-Jeong) ¿©Çö¾ç(Yeo Hyun-Yang) ÀåÈñÁø(Chang Hee-Jin) ÀåÈñÁø(Chang Hee-Jin) ±èº¸Çö(Kim Bo-Hyun) È«Àº°æ(Hong Eun-Kyung) ¹ÚÁß¿ø(Park Joong-Won)

• Cancer Research and Treatment  2016³â 48±Ç 4È£ 1229~1242

• Estrogen-related receptor ¥ã is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27

• ±èÁöÇö(Kim Ji-Hyun) ÃÖ¿¬°æ(Choi Yeon-Kyung) º¯ÁرÔ(Byun Jun-Kyu) ±è¹Ì°æ(Kim Mi-Kyung) °­À¯³ª(Kang Yu-Na) ±è¼ºÇå(Kim Seong-Heon) À̽¿ì(Lee Sung-Woo) À庴±¹(Jang Byoung-Kuk) ¹Ú±Ù±Ô(Park Keun-Gyu)

• Experimental & Molecular Medicine  2016³â 48±Ç 3È£ 9~9

• Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

• À±È«ÀÎ(Yoon Hong-In) ¼Û±âÁØ(Song Ki-Jun) ÀÌÀÍÀç(Lee Ik-Jae) ±èµµ¿µ(Kim Do-Young) Çѱ¤Çù(Han Kwang-Hyub) ¼ºÁø½Ç(Seong Jin-Sil)

• Cancer Research and Treatment  2016³â 48±Ç 1È£ 190~197

• A feasibility study evaluating the relationship between dose and focal liver reaction in stereotactic ablative radiotherapy for liver cancer based on intensity change of Gd-EOB-DTPA-enhanced magnetic resonance images

• Á¤»óÈÆ(Jung Sang-Hoon) À¯Á¤ÀÏ(Yu Jeong-Il) ¹ÚÈñö(Park Hee-Chul) ÀÓµµÈÆ(Lim Do-Hoon) ÇÑ¿µÀÌ(Han Young-Yih)

• Radiation Oncology Journal  2016³â 34±Ç 1È£ 64~75

• Hep3B °£¾Ï¼¼Æ÷¿¡¼­ °³¶Ë¾¦ÃßÃâ¹°·ÎºÎÅÍ Akt-mTOR-GSK3¥â ½ÅÈ£°æ·Î¿¡ ÀÇÇÑ apoptosis È¿°ú

• Apoptotic Effect of Extract from Artemisia annua Linne by Akt/mTOR/GSK-3¥â Signal Pathway in Hep3B Human Hepatoma Cells

• ±èÀºÁö(Kim Eun-Ji) ±è±ÙÅÂ(Kim Guen-Tae) ±èº¸¹Î(Kim Bo-Min) ÀÓÀº°æ(Lim Eun-Gyeong) ÇϼºÈ£(Ha Sung-Ho) ±è»ó¿ë(Kim Sang-Yong) ±è¿µ¹Î(Kim Young-Min)

• Journal of Life Science  2016³â 26±Ç 7È£ 764~771

• Noninvasive Diagnosis of Hepatocellular Carcinoma: Elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guidelines Compared with Other Guidelines and Remaining Issues

• :Yoon Jeong-Hee :Park Joong-Won/:Lee Jeong-Min

• Korean Journal of Radiology  2016³â 17±Ç 1È£ 7~24

• À°Á¾¾ç °£³» ´ã°ü¾Ï: Áõ·Êº¸°í ¹× ±¹³» ¹®Çå°íÂû

• Sarcomatoid Intrahepatic Cholangiocarcinoma: A Rare Case of Primary Liver Cancer

• À̵ÎÇõ(Lee Doo-Hyuck) ÇѱÔÇü(Han Kyu-Hyung) ¾È¼±¿µ(Ann Sun-Young) ±è»ó¼±(Kim Sang-Sun) ½ÅÇö¼º(Shin Hyun-Sung) ¹æ±â¹è(Bang Ki-Bae) ÃÖÁØÈ£(Choi Jun-Ho) ±è¼®¹è(Kim Suk-Bae) ÀÌ¿ø¾Ö(Lee Won-Ae) ¼ÛÀÏÇÑ(Song Il-Han)

• Journal of Liver Cancer  2016³â 16±Ç 2È£ 139~144

• Barcelona Clinic Liver Cancer Áß°£ º´±â °£¼¼Æ÷¾ÏÁ¾ ȯÀÚÀÇ º´±â ¼¼ºÐÈ­

• Subclassification of Hepatocellular Carcinoma with Barcelona Clinic Liver Cancer Intermediate Stage

• ÀÌÇý¿ø:Lee Hye-Won ±è½Â¾÷:Kim Seung-Up/¹ÚÁØ¿ë:Park Jun-Yong/±èµµ¿µ:Kim Do-Young/¾È»óÈÆ:Ahn Sang-Hoon/Çѱ¤Çù:Han Kwang-Hyub/±è¹ü°æ:Kim Beom-Kyung

• Journal of Liver Cancer  2016³â 16±Ç 1È£ 17~22

• Evaluation of the Outcome after Transarterial Chemoembolization; Refinement of Barcelona Clinic Liver Cancer Stage-B from Eastern Point of View

• :Izumi Namiki ÀúÀÚ¾øÀ½:No authors listed

• Journal of Liver Cancer  2016³â 16±Ç 1È£ 7~11

• °£¾Ï °ËÁø ±Ç°í¾È

• The Korean guideline for hepatocellular carcinoma surveillance

• ±èµµ¿µ(Kim Do-Young) ±èÇöÁ¤(Kim Hyun-Jung) Á¤½ÂÀº(Jung Seung-Eun) ±è»ó±Õ(Kim Sang-Gyune) ±èÇüÁØ(Kim Hyung-Joon) ½Åµ¿Çö(Sinn Dong-Hyun) ÀÌ¿ëÁÖ(Lee Yong-Joo) Á¤¿ì°æ(Jeong Woo-Kyoung) Ãֱͼ±(Choi Kui-Son) Çã³»À±(Heo Nae-Yun) ±èµ¿ÁØ(Kim Dong-Joon) ±è¿µ¼®(Kim Young-Seok) ±è¿ë¹ü(Kim Yong-Bum) ±èÀ±ÁØ(Kim Yoon-Jun) ±èÇü·Ä(Kim Hyoung-Ryoul) ¹Ú¹Î¼±(Park Min-Seon) ÀÌÂùÈ­(Lee Chan-Wha) Ź¿ø¿µ(Tak Won-Young) Á¤ÁöÇý(Chung Ji-Hye) ±è¼ö¿µ(Kim Soo-Young) ±è¿­(Kim Yeol) ÀÌ¿øö(Lee Won-Chul) ±èÈ«¼ö(Kim Hong-Soo)

• ´ëÇÑÀÇ»çÇùȸÁö  2015³â 58±Ç 5È£ 385~397

• °¨±âÀÇ ¾à¹°¿ä¹ý

• Drug therapy for the common cold

• ±è¼ö¿µ(Kim Soo-Young)

• ´ëÇÑÀÇ»çÇùȸÁö  2015³â 58±Ç 2È£ 147~153

• Trends of liver cancer and its major risk factors in Korea

• ÀÌÀº¿µ(Lee Eun-Young) (Mai Tran Thi Xuan) (Chang Yoon-Jun) ±â¸ð¶õ(Ki Mo-Ran)

• Epidemiology and Health  2015³â 37±Ç 1È£ 6~0

• Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions

• ¹è¼±Çö(Bae Sun-Hyun) ±è¹Ì¼÷(Kim Mi-Sook) Àå¿øÀÏ(Jang Won-Il) Á¶Ã¶±¸(Cho Chul-Koo) À¯ÇüÁØ(Yoo Hyung-Jun) ±è±Ý¹è(Kim Kum-Bae) ÇÑöÁÖ(Han Chul-Ju) ¹Ú¼öö(Park Su-Cheol) À̵¿ÇÑ(Lee Dong-Han)

• Journal of Korean Medical Science  2015³â 30±Ç 8È£ 1055~1061

• ´ÙÁßÇ¥Àû °£¾ÏÀÇ Á¤À§ÀûüºÎ¹æ»ç¼±Ä¡·á¿¡¼­ ¹«ÆíÆòÈ­¿©°ú±â¼±Áú ¿ëÀûº¯Á¶È¸ÀüÄ¡·áÀÇ À¯¿ë¼º Æò°¡

• A Study of volumetric modulated arc therapy for stereotactic body radiation therapy in case of multi-target liver cancer using flattening filter free beam

• ¿°¹Ì¼÷(Yeom Mi-Suk) À±ÀÎÇÏ(Yoon In-Ha) È«µ¿±â(Hong Dong-Ki) ¹é±Ý¹®(Back Geum-Mun)

• ´ëÇѹæ»ç¼±Ä¡·áÇÐȸÁö  2015³â 27±Ç 1È£ 31~43

• °£¾Ï È£Èíµ¿Á¶ ¹æ»ç¼±Ä¡·á ȯÀÚÀÇ È£Èí½ÅÈ£ºÐ¼®

• Respiratory signal analysis of liver cancer patients with respiratory-gated radiation therapy

• °­µ¿ÀÓ(Kang Dong-Im) Á¤»óÈÆ(Jung Sang-Hoon) ±èöÁ¾(Kim Chul-Jong) ¹ÚÈñö(Park Hee-Chul) ÃÖº´±â(Choi Byeong-Ki)

• ´ëÇѹæ»ç¼±Ä¡·áÇÐȸÁö  2015³â 27±Ç 1È£ 23~30

• Preference elicitation approach for measuring the willingness to pay for liver cancer treatment in Korea

• (Cho Dong-Hun) Á¶Ã¢ÀÍ(Jo Chang-Ik)

• Clinical and Molecular Hepatology  2015³â 21±Ç 3È£ 268~278

• An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenib

• Á¤µ¿È¯(Jung Dong-Hwan) Ȳ½Å(Hwang Shin) ¼Û±â¿ø(Song Gi-Won) ·ù¹é¿­(Ryoo Baek-Yeol) ±è³ª¿µ(Kim Na-Young) ŹÀº¿µ(Tak Eun-Young) È«Çý³²(Hong Hea-Nam)

• Çѱ¹°£´ãÃé¿Ü°úÇÐȸÁö  2015³â 19±Ç 1È£ 1~5

• 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma

• (Korean Liver Cancer Study Group) ±¹¸³¾Ï¼¾ÅÍ(National Cancer Center)

• Korean Journal of Radiology  2015³â 16±Ç 3È£ 465~522

• °£¾ÏÀÇ °íÁÖÆÄ ¿­ Ä¡·á¼ú¿¡ »ç¿ëµÇ´Â Àü±ØÀÇ Á¾·ùº° Ä¡·á ¸éÀû ºñ±³ - 15Gage ³»ºÎ ³Ã°¢Çü Àü±Ø, Cool wet-tip Àü±ØÀ» Áß½ÉÀ¸·Î

• Comparison of the treatment area type of electrode used for radiofrequency ablation of liver cancer : Focusing on the 15G cool-tip and CWT electrode

• À̼º±¸(Lee Sung-Gu) ±èÇöÁø(Kim Hyeon-Jin) ÀÌÇüÁø(Lee Hyung-Jin) Á¤¾çÈ­(Chung Yang-Hwa) ÀÌ¿øÈ«(Lee Won-Hong)

• ´ëÇÑÃÊÀ½ÆÄÀǷ῵»óÇÐȸÁö  2015³â 6±Ç 1È£ 79~85

• Cost-Effectiveness of Liver Cancer Screening in Adults at High Risk for Liver Cancer in the Republic of Korea

• ÀÌ¿ëÈ­(Lee Young-Hwa) Ãֱͼ±(Choi Kui-Son) ÀüÀç°ü(Jun Jae-Kwan) ¼­¹Ì³ª(Suh Mi-Na) ÀÌÈÄ¿¬(Lee Hoo-Yeon) ±èÀ±³²(Kim Youn-Nam) ³²Á¤¸ð(Nam Chung-Mo) ¹ÚÀº¾Æ(Park Eun-Ah) Á¶¿ìÇö(Cho Woo-Hyun)

• Cancer Research and Treatment  2014³â 46±Ç 3È£ 223~233

• Preclinical Efficacy Testing for Stomach and Liver Cancers

• ¹ÚÁØ¿ø(Park Jun-Won) (Baek Nam-Suk) À̼®Ã¶(Lee Seok-Cheol) ¿À¼öÁø(Oh Su-Jin) (Jang Seok-Hoon) ±èÀÎÈÄ(Kim In-Hoo) ±è´ë¿ë(Kim Dae-Yong) ±èÇбÕ(Kim Hark-Kyun)

• Cancer Research and Treatment  2014³â 46±Ç 2È£ 186~193

• Knockdown of 14-3-3¥æ enhances radiosensitivity and radio-induced apoptosis in CD133+ liver cancer stem cells

• ÀÌ¿µ±â(Lee Young-Ki) Çã¿øÈñ(Hur Won-Hee) À̼º¿ø(Lee Sung-Won) È«¼º¿ì(Hong Sung-Woo) ±è¼º¿ì(Kim Sung-Woo) ÃÖÁ¤Àº(Choi Jung-Eun) À±½Â±Ô(Yoon Seung-Kew)

• Experimental & Molecular Medicine  2014³â 46±Ç 2È£ 5~0

• ȯÀÚ ÀÚ¼¼°¡ °£ÀÇ ¹æ»ç¼± Ä¡·á ½Ã ¼±·®¿¡ ¹ÌÄ¡´Â ¿µÇâ

• The effect of patient position on dose in radiation therapy of liver cancer

• Á¤¿ø¼®(Jung Won-Seok) ±èÁÖÈ£(Kim Joo-Ho) ±è¿µÀç(Kim Young-Jae) ½Å·É¹Ì(Shin Ryung-Mi) ¿ÀÁ¤ÈÆ(Oh Jeong-Hun) Á¤°Ç¾Æ(Jeong Geon-A) Á¶ÁØ¿µ(Jo Jun-Young) ±è±âö(Kim Gi-Chul) ÃÖűÔ(Choi Tae-Gu)

• ´ëÇѹæ»ç¼±Ä¡·áÇÐȸÁö  2014³â 26±Ç 1È£ 1~9

• Discrepancies between Calculated and Delivered Dose Distributions of Respiratory Gated IMRT Fields according to the Target Motion Ranges for Lung and Liver Cancer Patients

• ±è¿µ±¹(Kim Young-kuk) ³ëÅÂÀÍ(Ro Tae-Ik) Á¤Å½Ä(Jeung Tae-Sig) ¸¶¼±¿µ(Ma Sun-Young) ÃÖÁöÈÆ(Choi Ji-Hoon) ÀÓ»ó¿í(Lim Sang-Wook)

• Progress in Medical Physics  2014³â 25±Ç 4È£ 242~247

• Evaluation of Dose Distributions Recalculated with Per-field Measurement Data under the Condition of Respiratory Motion during IMRT for Liver Cancer

• ¼ÛÁÖ¿µ(Song Ju-Young) ±è¿ëÇù(Kim Yong-Hyeob) Á¤Àç¿í(Jeong Jae-Uk) À±¹Ì¼±(Yoon Mee-Sun) ¾È¼ºÀÚ(Ahn Sung-Ja) Á¤¿õ±â(Chung Woong-Ki) ³²ÅñÙ(Nam Taek-Keun)

• Progress in Medical Physics  2014³â 25±Ç 2È£ 79~88

• °£°æº¯ ȯÀÚ¿¡¼­ °£¼¼Æ÷¾ÏÀ¸·Î ¿ÀÀÎµÈ ÀüÀ̼º °£¾Ï

• Metastatic Liver Cancer Mimicking Hepatocellular Carcinoma in Alcoholic Cirrhosis

• ±èÈñ¿¬(Kim Hee-Yeon) ±èâ¿í(Kim Chang-Wook) ÀÌâµ·(Lee Chang-Don) À̼ö¸²(Lee Su-Lim) ¿øÀ¯µ¿(Won Yoo-Dong) ±è¿¹ÀÏ(Kim Ye-Il)

• Journal of Liver Cancer  2014³â 14±Ç 1È£ 41~45

• 2011³âµµ ´ÜÀÏ º´¿ø¿¡¼­ °æÇèÇÑ °£¾Ï ±¹°¡¾Ï°ËÁø»ç¾÷

• The Korean National Liver Cancer Surveillance Program: Experience of a Single Healthcare Center in 2011

• ½ÉÀçÁØ(Shin Jae-Jun) ¹ÚÇöÁø(Park Hyun-Jin) ±èÁ¤¿í(Kim Jung-Wook) ȲÀºÁ¤(Hwang Eun-Jung) ÀÌâ±Õ(Lee Chang-Kyun) ÀåÀ翵(Jang Jae-Young) ¹Ú¼ºÁø(Park Seong-Jin) ÃÖÇö¸²(Choi Hyun-Rim) ±èº´È£(Kim Byung-Ho)

• ´ëÇѳ»°úÇÐȸÁö  2013³â 84±Ç 5È£ 672~680

• A comparison of antioxidant activity of Korean White and Red Ginsengs on H2O2-induced oxidative stress in HepG2 hepatoma cells

• ¼Õ»óÇö(Sohn Sang-Hyun) ±è½Ã°ü(Kim Si-Kwan) ±è¿µ¿Á(Kim Young-Ock) ±èÇüµ·(Kim Hyung-Don) ½ÅÀ¯¼ö(Shin Yu-Su) ¾ç½Â¿Á(Yang Seung-Ok) ±è½ÂÀ¯(Kim Seung-Yu) ÀÌ»ó¿ø(Lee Sang-Won)

• Journal of Ginseng Research  2013³â 37±Ç 4È£ 442~450

• Status of Primary Liver Cancer Found through Routine Health Check-up

• ÀÌâÇö(Lee Chang-Hyun) ¾çÁ¾ÀÎ(Yang Jong-In) º¯ÈñÁø(Byun Hee-Jin) °­Á¤¹¬(Kang Jung-Mook) (Choi Seoung-ho) ÀÓÁ¤À±(Yim Jeong-Yoon)

• Journal of Korean Medical Science  2013³â 28±Ç 10È£ 1449~1453

• ¹ßÈ¿ äõç¨ ÃßÃâ¹°ÀÌ Àΰ£ °£¾Ï¼¼Æ÷ÁÖ HepG2 È°¼º¿¡ ¹ÌÄ¡´Â ¿µÇâ

• Effect of Fermented Artemisiae Argyi Folium on Human Hepatoma Cell Line HepG2 Activity

• ÇÑÈ¿»ó:Han Hyo-Sang ÀúÀÚ¾øÀ½:No authors listed

• ´ëÇѺ»ÃÊÇÐȸÁö  2013³â 28±Ç 3È£ 107~113

• Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma

• ¹è¼±Çö(Bae Sun-Hyun) ±è¹Ì¼÷(Kim Mi-Sook) Á¶Ã¶±¸(Cho Chul-Koo) ±è±Ý¹è(Kim Kum-Bae) À̵¿ÇÑ(Lee Dong-Han) ÇÑöÁÖ(Han Chul-Ju) ¹Ú¼öö(Park Su-Cheol) ±è¿µÇÑ(Kim Young-Han)

• Journal of Korean Medical Science  2013³â 28±Ç 2È£ 213~219

• °£¾ÏȯÀÚ¿¡ ´ëÇÑ ¼¼±âÁ¶Àý¹æ»ç¼±Ä¡·á¿¡¼­ÀÇ 2Â÷ »ê¶õ¼±·®Æò°¡

• Estimation of Secondary Scattered Dose from Intensity-modulated Radiotherapy for Liver Cancer Cases

• ±èµ¿¿í(Kim Dong-Wook) ÀÌÇöÈ£(Lee Hyun-Ho) À±¸í±Ù(Yoon Myong-Geun) Á¤¿ø±Ô(Chung Weon-Kuu) ¹è¼±Çö(Bae Sun-Hyun) ½Åµ¿¿À(Shin Dong-Oh) Á¤±¤ÁÖ(Chung Kwang-Zoo) ÀÓ¿µ°æ(Lim Young-Kyung) ½Åµ¿È£(Shin Dong-Ho) À̼¼º´(Lee Se-Byeong)

• Progress in Medical Physics  2013³â 24±Ç 4È£ 295~302

• Sorafenib¿¡ ºÎºÐ ¹ÝÀÀÀ» º¸ÀÎ Æó ÀüÀÌ °£¼¼Æ÷¾ÏÁ¾ 1¿¹

• A Case of Pulmonary Metastasis from Hepatocellular Carcinoma Partially Responsive to Sorafenib

• Çã³»À±(Heo Nae-Yun) ÀÌ¿µ»ó(Lee Yung-Sang) ¼­µ¿Áø(Suh Dong-Jin) Á¤¿µÈ­(Chung Young-Hwa) ÀÓ¿µ¼®(Lim Young-Suk) ½ÉÁÖÇö(Shim Ju-Hyun) ÀÌÇÑÁÖ(Lee Han-Chu)

• ´ëÇÑ°£¾Ï¿¬±¸ÇÐȸÁö  2010³â 10±Ç 1È£ 52~54

• ÁøÇ༺ °£¼¼Æ÷¾ÏÁ¾ ȯÀÚ¿¡¼­ ¼Ò¶óÆä´ÕÀÇ Ä¡·á È¿°ú¿Í ¾ÈÁ¤¼º

• Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma

• ÇãÁ¤(Heo Jeong)

• Korean Journal of Hepatology  2009³â 15±Ç 2È£ 227~230

• ¿ø¹ß¼º °£¾ÏÀÇ ºÐÇÒ Á¤À§¹æ»ç¼±Ä¡·á È¿°ú

• Effects of Fractionated Stereotactic Radiotherapy for Primary Hepatocellular Carcinoma

• ÃÖº´¿Á/Choi BO °­±â¹®/ÀåÈ«¼®/ÀÌ»ó¿í/°­¿µ³²/ä±Ô¿µ/ÃÖÀϺÀ/Kang KM/Jang HS/Lee SW/Kang YN/Chai GY/Choi IB

• ´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö  2005³â 23±Ç 2È£ 92~97

• °£¼¼Æ÷¾ÏÁ¾ÀÇ ¼ö¼ú Á÷ÈÄ Ä¡¸íÀû Àç¹ßÀÇ À§ÇèÀÎÀÚ ºÐ¼®

• Risk Factors for Immediate Postoperative Fatal Recurrence of Hepatocellular Carcinoma

• ±èºÀ¿Ï(Kim Bong-Wan) ±èÀαÔ(Kim In-Gyu) ±è¿µ¹è(Kim Young-Bae) ¿ÕÈñÁ¤(Wang Hee-Jung) ±è¸í¿í(Kim Myung-Wook)

• Çѱ¹°£´ãÃé¿Ü°úÇÐȸÁö  2005³â 9±Ç 1È£ 36~43